To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed Instil Bio raises $320m for IPO
Instil Bio, a clinical-stage biopharmaceutical company, has raised $320 million for its IPO after pricing its 16 million shares at $20 per share.
